Physician

Andrew J Gordon, M.D.

According to 2025 Medicare claims, Andrew Gordon, M.D. (NPI: 1508898206) practices neurology in the Lake County, IL market, with the plurality of this provider's patient population coming from Lake, IL. This provider's primary affiliated billing organization is NORTHWEST NEUROLOGY, LTD (NPI: 1427094077; TIN: 363329019) and primary practice location at 60010-2542. Gordon is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), participating under the MSSP model.

Gordon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 468 traditional Medicare patients, billed 136,892 HCPCS/CPT codes, and received $8,136,020 in Medicare payments. The top billing code was 95911 (Nerve conduction, 9-10 studies). Part D data shows 824 prescription claims across 216 beneficiaries totaling $1,184,173 in drug costs, led by Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50). 2020 DME data shows 28 claims. Open Payments data shows 326 records totaling $182,054. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $214,803 to $8,136,020. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,145,923 and ending at $1,184,173. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	631	3,439	$214,803
2016	627	5,027	$234,430
2017	749	5,134	$283,720
2018	783	10,984	$286,745
2019	787	23,613	$1,946,112
2020	528	34,331	$2,840,672
2021	426	57,031	$4,310,196
2022	422	68,189	$5,099,436
2023	497	88,417	$5,993,560
2024	468	136,892	$8,136,020

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	321	2,653	$1,145,923
2016	340	2,385	$991,588
2017	317	2,087	$687,757
2018	283	1,845	$1,177,846
2019	270	1,693	$914,453
2020	258	1,624	$499,405
2021	235	1,395	$563,203
2022	192	1,126	$386,231
2023	228	833	$417,174
2024	216	824	$1,184,173

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	28	$551
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95911	Nerve conduction, 9-10 studies	68	69	$158
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	85	140	$141
95910	Nerve conduction, 7-8 studies	142	143	$136
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	280	566	$76
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	79	207	$51

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	11	308	$327,265
Nurtec Odt	Rimegepant Sulfate	16	495	$31,747
Ubrelvy	Ubrogepant	11	365	$18,975
Mycophenolate Mofetil	Mycophenolate Mofetil	27	2,122	$8,700
Pyridostigmine Bromide	Pyridostigmine Bromide	81	4,555	$5,819

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	309	$166,628	Alexion Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	17	$15,427	Regeneron Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew J. Gordon, M.D.?

Tedicare shows public-source Medicare data for Andrew J. Gordon, M.D. (NPI 1508898206), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew J. Gordon, M.D. have ACO affiliation data?

Andrew J. Gordon, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033).

What billing organization is linked to Andrew J. Gordon, M.D.?

Andrew J. Gordon, M.D. is linked to NORTHWEST NEUROLOGY, LTD (billing NPI 1427094077) in the available physician profile data.

Does Andrew J. Gordon, M.D. have Open Payments data?

Andrew J. Gordon, M.D. has 326 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.